Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as a skin-ageing or anti-ageing medicine in the United Kingdom. This page is a literature-context overview of compound families discussed in published skin-ageing research. It is not personal-use guidance. Peptides Lab UK supplies research-use-only laboratory reference compounds. Products are…
This resource is prepared for researchers and academic institutions comparing Epithalon and MOTS-C as research-use-only (RUO) compounds in pre-clinical ageing biology models. Both compounds are for in vitro and pre-clinical investigation only and are entirely distinct from anti-ageing therapeutics. This comparison is distinct from the previous Epitalon vs MOTS-C post (ID 77498) — which focused…
Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as an anti-inflammatory medicine in the United Kingdom. This page is a literature-context overview of compound families discussed in published inflammation research. It is not personal-use guidance. Peptides Lab UK supplies research-use-only laboratory reference compounds. Products are not for…
Important regulatory notice. No peptide is currently licensed by the MHRA as a cognitive-enhancement medicine in the United Kingdom. This page is a literature-context overview of compound families discussed in published cognitive-neuroscience research. It is not personal-use guidance and Peptides Lab UK does not endorse any human or veterinary use of any unlicensed peptide for…
Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as a cancer treatment in the United Kingdom. This page is a literature-context overview of compound families discussed in published cancer biology research. It is not personal-use guidance. Peptides Lab UK does not endorse or recommend any human or…
This resource is prepared for researchers and academic institutions studying cardiovascular risk biology using research-use-only (RUO) peptide compounds in pre-clinical models. All compounds discussed are for in vitro and pre-clinical investigation and are entirely distinct from licensed cardiovascular therapeutics. This hub is distinct from the cardiovascular research hub (ID 77111), the heart failure hub (ID…
Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as a treatment for IBS or other gastrointestinal disease in the United Kingdom. This page is a literature-context overview of compound families discussed in published gastrointestinal research. It is not personal-use guidance. Peptides Lab UK supplies research-use-only laboratory reference…
This resource is prepared for researchers and academic institutions studying reproductive biology using research-use-only (RUO) peptide compounds in pre-clinical models. All compounds discussed are for in vitro and pre-clinical investigation and are entirely distinct from clinical fertility treatment or contraceptive applications. This hub is distinct from the reproductive research hub (ID 77159), the PCOS hub…
This resource is prepared for registered researchers and academic institutions evaluating research-use-only (RUO) peptide compounds in skeletal muscle and sarcopenia biology contexts. All compounds discussed are strictly for in vitro and pre-clinical in vivo research and are entirely distinct from therapeutic or supplemental applications. This hub is distinct from the sarcopenia overview hub (ID 77396),…
For research use only (RUO). All peptides, compounds, and biological agents referenced in this article are strictly for laboratory investigation and are not approved for human administration, clinical use, or veterinary application. This resource is intended for qualified scientists and institutions engaged in immunology research. It is distinct from our disease-specific immunology hubs — Multiple…
Important regulatory notice. No peptide is currently licensed by the MHRA as a longevity or anti-ageing medicine in the United Kingdom. This page is a literature-context overview of compound families discussed in published longevity research. It is not personal-use guidance and Peptides Lab UK does not endorse any human or veterinary use of any unlicensed…
For research use only (RUO). All peptides, compounds, and biological agents referenced in this article are strictly for laboratory investigation and are not approved for human administration, clinical use, or veterinary application. This resource is intended for qualified scientists and institutions engaged in neuropsychiatry and affective disorder research. It is distinct from our Parkinson's disease…
